Carcinogenesis, Vol 19, 2107-2113, Copyright © 1998 by Oxford University Press
MF Bolontrade, MC Stern, RL Binder, JC Zenklusen, IB Gimenez-Conti and CJ Conti
In this study we have analyzed the vascular response induced in the two-
stage carcinogenesis model in SENCAR mice. The role of angiogenesis has not
been explored in this model, which is the paradigm of multistage
carcinogenesis and a model for neoplastic lesions derived from exophytic
premalignant lesions (e.g. colon carcinoma, bladder papilloma). We
investigated if angiogenesis is involved in the formation of papillomas and
in the progression from papilloma to carcinoma. To this end we analyzed the
vasculature of normal and hyperplastic skin, focal epidermal hyperplasias
that are precursors of papillomas, papillomas at different stages and
squamous cell carcinomas. We also analyzed the vascularization of
papillomas induced in two strains of mice that differ in their
susceptibility to malignant progression. We show here that angiogenesis is
turned on in the earliest stages of papilloma formation. In late stages,
regardless of state of progression, the predominant response is an increase
in the size of blood vessels. Thus, in the SENCAR mouse model,
representative of exophytic tumors, the angiogenesis switch is a very early
event, probably mechanistically related to the development of the primarily
exophytic lesions. Therefore, the density of blood vessels cannot be used
as a predictor of malignant progression in this model.
ARTICLES
Angiogenesis is an early event in the development of chemically induced skin tumors
Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Smithville 78957, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Scortegagna, R. J. Martin, R. D. Kladney, R. G. Neumann, and J. M. Arbeit Hypoxia-Inducible Factor-1{alpha} Suppresses Squamous Carcinogenic Progression and Epithelial-Mesenchymal Transition Cancer Res., March 15, 2009; 69(6): 2638 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin, F. J. Duncan, T. Keiser, S. Shin, D. F. Kusewitt, T. Oberyszyn, A. R. Satoskar, and A. M. VanBuskirk Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC) FASEB J, March 1, 2009; 23(3): 720 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Lai, S. Li, C.-Y. Chai, C.-Y. Lo, S. Dushenkov, C.-T. Ho, M.-H. Pan, and Y.-J. Wang Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin Carcinogenesis, December 1, 2008; 29(12): 2415 - 2424. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Ansari, J. E. Rundhaug, and S. M. Fischer Multiple Signaling Pathways Are Responsible for Prostaglandin E2-Induced Murine Keratinocyte Proliferation Mol. Cancer Res., June 1, 2008; 6(6): 1003 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Martinez-Cruz, M. Santos, M. F. Lara, C. Segrelles, S. Ruiz, M. Moral, C. Lorz, R. Garcia-Escudero, and J. M. Paramio Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of Retinoblastoma and Trp53 Tumor Suppressors Cancer Res., February 1, 2008; 68(3): 683 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brideau, M. J. Makinen, H. Elamaa, H. Tu, G. Nilsson, K. Alitalo, T. Pihlajaniemi, and R. Heljasvaara Endostatin Overexpression Inhibits Lymphangiogenesis and Lymph Node Metastasis in Mice Cancer Res., December 15, 2007; 67(24): 11528 - 11535. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Segrelles, S. Ruiz, M. Santos, J. Martinez-Palacio, M. F. Lara, and J. M. Paramio Akt mediates an angiogenic switch in transformed keratinocytes Carcinogenesis, July 1, 2004; 25(7): 1137 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. de Cicco, J. C. Watson, D. E. Bassi, S. Litwin, and A. J. Klein-Szanto Simultaneous Expression of Furin and Vascular Endothelial Growth Factor in Human Oral Tongue Squamous Cell Carcinoma Progression Clin. Cancer Res., July 1, 2004; 10(13): 4480 - 4488. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Nayha, J. Laitakari, and F. Stenback Stage-Dependent Expression of an Angiogenic Agent and Vascular Organization in Experimental Skin Tumor Development Toxicol Pathol, August 1, 2003; 31(5): 539 - 548. [Abstract] [PDF] |
||||
![]() |
C. J. Conti Vascular Endothelial Growth Factor: Regulation in the Mouse Skin Carcinogenesis Model and Use in Antiangiogenesis Cancer Therapy Oncologist, August 1, 2002; 7(90003): 4 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Casanova, F. Larcher, B. Casanova, R. Murillas, M. J. Fernandez-Acenero, C. Villanueva, J. Martinez-Palacio, A. Ullrich, C. J. Conti, and J. L. Jorcano A Critical Role for ras-mediated, Epidermal Growth Factor Receptor-dependent Angiogenesis in Mouse Skin Carcinogenesis Cancer Res., June 1, 2002; 62(12): 3402 - 3407. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hawighorst, M. Skobe, M. Streit, Y.-K. Hong, P. Velasco, L. F. Brown, L. Riccardi, B. Lange-Asschenfeldt, and M. Detmar Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma Growth Am. J. Pathol., April 1, 2002; 160(4): 1381 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lan, C. Trempus, and S. K. Gilmour Inhibition of Ornithine Decarboxylase (ODC) Decreases Tumor Vascularization and Reverses Spontaneous Tumors in ODC/Ras Transgenic Mice Cancer Res., October 1, 2000; 60(20): 5696 - 5703. [Abstract] [Full Text] |
||||
![]() |
C. Go, P. Li, and X.-J. Wang Blocking Transforming Growth Factor {beta} Signaling in Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated with Increased Angiogenesis Cancer Res., June 1, 1999; 59(12): 2861 - 2868. [Abstract] [Full Text] [PDF] |
||||







